Choi Yoon Kyung, Yang Ji Hyun, Ahn Shin Young, Ko Gang Jee, Oh Se Won, Kim Myung Gyu, Cho Won Yong, Jo Sang Kyung
Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
Department of Internal Medicine, Korea University Guro Hospital, Seoul, Korea.
Kidney Res Clin Pract. 2019 Mar 31;38(1):42-48. doi: 10.23876/j.krcp.18.0052.
Retroperitoneal fibrosis (RPF) is a rare disease characterized by fibroinflammatory tissue in the periaortic or periiliac retroperitoneum, where it frequently encases ureters. There is emerging evidence that a subset of this disease is part of a spectrum of multisystemic autoimmune diseases collectively referred to as "immunoglobulin G4 (IgG4)-related disease".
We retrospectively analyzed 27 idiopathic RPF patients and identified a subset as IgG4-related RPF, which we categorized according to recently published comprehensive diagnostic criteria. We compared clinical and laboratory characteristics and response to treatment between the two groups.
Of 27 total patients, 16 (59.3%) were diagnosed as having IgG4-related RPF, and these were predominantly male. They were also significantly older and more likely to have other organ involvement, hydronephrosis, and postrenal acute kidney injury (AKI) compared to those with idiopathic RPF. However, there was no difference in response rate to systemic steroid treatment.
IgG4-related RPF accounts for a substantial portion of RPF cases previously identified as "idiopathic RPF" in Korea. Clinical and laboratory characteristics of IgG4-related RPF are similar to those of idiopathic RPF except for a striking male predominance, older age, and higher incidence of postrenal AKI in IgG4-related RPF. More comprehensive, prospective studies are needed to clearly distinguish IgG4-related RPF from idiopathic RPF based on clinical manifestation and to further assess treatment response and long-term prognosis.
腹膜后纤维化(RPF)是一种罕见疾病,其特征为主动脉周围或髂血管周围腹膜后的纤维炎性组织,常累及输尿管。越来越多的证据表明,该疾病的一部分属于多系统自身免疫性疾病谱,统称为“免疫球蛋白G4(IgG4)相关疾病”。
我们回顾性分析了27例特发性RPF患者,并根据最近公布的综合诊断标准将其中一部分确定为IgG4相关RPF。我们比较了两组患者的临床和实验室特征以及治疗反应。
27例患者中,16例(59.3%)被诊断为IgG4相关RPF,且以男性为主。与特发性RPF患者相比,他们年龄更大,更易出现其他器官受累、肾积水和肾后性急性肾损伤(AKI)。然而,全身类固醇治疗的反应率并无差异。
在韩国,IgG4相关RPF占之前被认定为“特发性RPF”病例的很大一部分。IgG4相关RPF的临床和实验室特征与特发性RPF相似,不同之处在于IgG4相关RPF男性占比显著、年龄较大且肾后性AKI发病率较高。需要开展更全面的前瞻性研究,以便根据临床表现明确区分IgG4相关RPF与特发性RPF,并进一步评估治疗反应和长期预后。